Alcaligenes denitrificans subsp. xylosoxidans (11) , previously designated Achromobacter xylosoxidans (24) , is an aerobic, glucose-nonfermentative, gram-negative bacillus. It is motile by means of peritrichous flagella and produces acid oxidatively from xylose. A. denitrificans subsp. xylosoxidans has been isolated from various environmental and hospital water sources (6, 9, 10) and also from clinical specimens, including ear discharge, blood, cerebrospinal fluid, wound, peritoneal fluid, urine, stool, throat, sputum, and tracheal aspirate specimens (21) . In many instances of isolation, this organism is considered as a colonizer and a potential pathogenic role is generally dismissed. However, well-documented infections have been reported on several occasions. These include neonatal meningitis (16) , ventriculitis after neurosurgery (22) , fatal bacteremia (6, 9, 14, 20) , pneumonia (2, 5, 20, 23) , urinary tract infections (10), peritonitis (15, 20) , aortic root graft infection (18) , endocarditis (13) , and otitis externa (19) . Nosocomial outbreaks usually associated with an aqueous source (usually nonbacteriostatic saline or hemodialysis fluid) have also been described (14, 20) . Infected patients in these outbreaks frequently had compromised host defenses or undei'ying diseases, such as malignancy or renal insufficiency.
Antimicrobial susceptibility data for A. denitrificans subsp. xylosoxidans are scarce. The multiresistance pattern of susceptibility of this organism to several antibiotics has been emphasized in previous reports (2, 3, 5, 6, 10, 15, 20, 22, 24 (20) . Reference strain ATCC 27061 was also included in the study. Confirmation of the identification was performed by biochemical tests by the method of Gilardi (8) and by chromatographic determination of the fatty acid cell wall profile (4) .
The MICs of the antimicrobial agents were determined by a microdilution broth method (1), using commercial plastic microdilution trays (Biotest-Serum-Institut, Dreieich, Federal Republic of Germany). Unsupplemented MuellerHinton broth was used in the microdilution trays. The trays were sealed in plastic bags and stored frozen at -20°C for a maximum of 6 weeks. Amoxycillin-clavulanic acid concentrations used were in a 2:1 proportion. Trays containing imipenem and ticarcillin-clavulanic acid were stored at -70°C. The inocula were prepared as follows. Four to five isolated colonies were picked from a 24-h culture on a blood agar plate and inoculated into 0.5 ml of brain heart infusion broth, which was then incubated for 4 h at 35°C. The actively growing broth culture was then diluted so as to match the turbidity of a McFarland 0.5 standard (ca. 108 CFU/ml). Further transfer of the bacterial suspension (200 ,ul) into a screw-cap tube containing 20 ml of sterile distilled H20 supplemented with 0.02% Tween 80 resulted in a 1/100 dilution. Samples (5 ,ul) of inoculum were then deposited with a multipoint plastic replicator into 0. Table 1 . Of 24 antibiotics tested, only 5 had some inhibitory activity: piperacillin, ticarcillin-clavulanic acid, ceftazidime, imipenem, and trimethoprim-sulfamethoxazole. Among the penicillins, piperacillin and ticarcillin-clavulanic acid exhibited good activity against most of the isolates (91% of the strains were inhibited by piperacillin at 64 ,ug/ml; 79% were inhibited by 2 ,ug of ticarcillin-clavulanic acid per ml, and 97% were inhibited by 32 ,ug/ml). All the strains were susceptible to imipenem, whereas none was inhibited by temocillin, amdinocillin, or aztreonam. Except ceftazidime (81% of isolates susceptible at 8 ,ug/ml), none of the expanded-spectrum cephalosporins tested was active against A. denitrificans subsp. xylosoxidans. Confirming the results of previous reports (2, 3, 5, 6, 10, 15, 20, 22, 24) , all the aminoglycosides (including amikacin) were found to lack activity against A. denitrificans subsp. xylosoxidans. Tri- methoprim-sulfamethoxazole, generally considered one of the most reliable antimicrobial agents against this species (2, 3, 5), was not uniformly active, one-third of our isolates being resistant to this drug. The new 4-quinolone derivatives displayed virtually no activity against A. denitrificans subsp. xylosoxidans. This last observation is worth mentioning because there is a growing interest in using these compounds for the treatment of different types of infections, including septic episodes of unknown origin. Of all the agents tested, imipenem alone showed consistent activity (70% of strains inhibited at 0.5 ,ug/ml; 91% at 2 ,ug/ml). Mechanisms of resistance to beta-lactam antibiotics in Achromobacter species were studied previously. Levesque et al. (12) described three different types of constitutive 13-lactamases (cephalosporinases) mediated either by nonconjugative plasmids or by genes of chromosomal origin. Fujii et al. (7) characterized a different ,-lactamase (of the penicillinase type) in 6 of 11 clinical isolates of A. denitrificans subsp. xylosoxidans. Interestingly, Fujii et al. found that sulbactam, clavulanic acid, and imipenem had low affinities for the ,B-lactamase and that the enzymatic activity was inhibited by clavulanic acid and sulbactam (7). Moreover, a diminished beta-lactam-antibiotic affinity for penicillin-binding protein 3 has been suggested and could also account for the lack of activity of most beta-lactams against this species. The uniform pattern of resistance to all new fluoroquinolone compounds and to the aminoglycosides suggests that a plasmid-mediated form of resistance is not the only mechanism involved but rather that the selection of bacterial mutants could also lead to resistance because of either an alteration of the DNA gyrase or defective transport of the agents through the cell envelope.
Overall, the antimicrobial susceptibility profile of A. denitrificans subsp. xylosoxidans demonstrated that this organism is resistant to many antibiotics, including the new 4-quinolone derivatives, the aminoglycosides, and most expanded-spectrum beta-lactams, except imipenem. Therapy against this uncommon opportunistic organism should be guided by an awareness of its unique antimicrobial susceptibility profile.
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